While targeted therapies have nearly doubled survival for some cancers, lung cancer continues to claim more lives than any ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC ...

Researchers found that treating precancerous pancreatic lesions with experimental KRAS inhibitors slowed tumor development and improved survival in mice, demonstrating the potential of intercepting ...

Australian biotech investors received a brutal reminder of the sector’s binary risk on Friday, as Immutep Ltd (ASX:IMM) ...

A newly released publication examines how deuterium concentration may influence gene activity in lung cancer cells. The study explores how shifts in this ...

Candel Therapeutics Inc (NASDAQ:CADL) is advancing plans to bring its lead cancer immunotherapy toward potential ...

A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, ...

“When a doctor tells you it’s stage 4, you think, ‘My life is over,'" said Amy Piccioli ...